Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT07179055 | An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye | PHASE2 | RECRUITING | 160 | — | — | Oct 1, 2025 | Sep 1, 2026 | Sep 17, 2025 | 5 | United States |
Corneal Staining will be assessed by the investigator on a scale of 0-4, with a higher number indicating a higher grade of staining.
| Arm | Type | Description |
|---|---|---|
| VSJ-110 Solution | EXPERIMENTAL | - |
| Placebo Solution | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| VSJ-110 | DRUG | ophthalmic solution |
| Placebo | DRUG | ophthalmic solution |
Inclusion Criteria: * Be at least 18 years of age of either gender and any race. * Provide written informed consent and sign the HIPAA form. * Be willing and able to follow all instructions and attend all study visits. Exclusion Criteria: * Use of any of the disallowed medications during the wash...